Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.74 USD
+0.05 (2.96%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LXRX 1.74 +0.05(2.96%)
Will LXRX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for LXRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LXRX
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
Lexicon (LXRX) Up as FDA Maintains Action Date for Zynquista
LXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lexicon (LXRX) to Reprioritize Portfolio, Slash Jobs, Stock Up
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Misses Revenue Estimates
Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates
Other News for LXRX
Piper Sandler Reaffirms Their Buy Rating on Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals Inc (LXRX) Q2 2024 Earnings Call Highlights: Strategic Advancements ...
Lexicon Pharmaceuticals (LXRX) Stock Surges Amid Positive Analyst Ratings
Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August
Buy Rating Affirmed for Lexicon Pharmaceuticals Based on Sotagliflozin’s Market Potential and Favorable Safety Data